According to a note out of Goldman Sachs this morning, it has held firm with its neutral rating and $9.00 price target.
- Forums
- ASX - By Stock
- BAL
- Regulatory hurdles - SAMR
Regulatory hurdles - SAMR
-
-
Share
These hurdles will make the rise of BAL so much steeper when the inevitable approvals occur.
I like when A2M posters bring doom to the BAL forum.
The shorters are going to regret their positions come SAMR and site visits could happen any day. That gives shorters 5 months max to exit.
When BAL receives an unexpected SAMR registration, shorters still upped their assault. I can see the pending expected SAMR will bring their undoing.
We all have a choice, hold, watch, short or sell. Watch, short or sell if you expect downside. Buy if you think site visits are near. It is really simple IMO.
Last edited by prosperity: 26/04/19 - There are more pages in this discussion • 41 more messages in this thread...
Featured News
Add BAL (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, MD & CEO
Anthony Noble
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online